日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The ECHELON-2 Trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma

ECHELON-2 试验:一项随机 III 期研究,探讨 brentuximab vedotin 与化疗联合治疗 CD30 阳性外周 T 细胞淋巴瘤的 5 年结果

S Horwitz, O A O'Connor, B Pro, L Trümper, S Iyer, R Advani, N L Bartlett, J H Christensen, F Morschhauser, E Domingo-Domenech, G Rossi, W S Kim, T Feldman, T Menne, D Belada, Á Illés, K Tobinai, K Tsukasaki, S-P Yeh, A Shustov, A Hüttmann, K J Savage, S Yuen, P L Zinzani, H Miao, V Bunn, K Fenton, 

Progression of undiagnosed cutaneous lymphoma after anti-tumor necrosis factor-alpha therapy

抗肿瘤坏死因子-α治疗后未确诊的皮肤淋巴瘤进展

Martinez-Escala, Maria Estela; Posligua, Alba L; Wickless, Heather; Rutherford, Audrey; Sable, Kimberly A; Rubio-Gonzalez, Belen; Zhou, Xiaolong A; Kaplan, Jason B; Pro, Barbara; Choi, Jaehyuk; Querfeld, Christiane; Rosen, Steven T; Guitart, Joan

Hemophagocytic Lymphohistiocytosis in Cutaneous T-Cell Lymphoma

皮肤T细胞淋巴瘤中的噬血细胞性淋巴组织细胞增生症

Lee, Dylan E; Martinez-Escala, M Estela; Serrano, Linda M; Zhou, Xiaolong A; Kaplan, Jason B; Pro, Barbara; Choi, Jaehyuk; Guitart, Joan

Rituximab plus hyper-CVAD alternating with MTX/Ara-C in patients with newly diagnosed mantle cell lymphoma: 15-year follow-up of a phase II study from the MD Anderson Cancer Center

利妥昔单抗联合高剂量环磷酰胺、长春新碱、阿霉素和地塞米松方案与甲氨蝶呤/阿糖胞苷交替用于新诊断的套细胞淋巴瘤患者:MD安德森癌症中心一项II期研究的15年随访结果

Chihara, Dai; Cheah, Chan Y; Westin, Jason R; Fayad, Luis E; Rodriguez, Maria A; Hagemeister, Fredrick B; Pro, Barbara; McLaughlin, Peter; Younes, Anas; Samaniego, Felipe; Goy, Andre; Cabanillas, Fernando; Kantarjian, Hagop; Kwak, Larry W; Wang, Michael L; Romaguera, Jorge E

Utility of ¹⁸fluoro-deoxyglucose positron emission tomography for prognosis and response assessments in a phase 2 study of romidepsin in patients with relapsed or refractory peripheral T-cell lymphoma

¹⁸氟脱氧葡萄糖正电子发射断层扫描在罗米地辛治疗复发或难治性外周T细胞淋巴瘤患者的II期研究中用于预后和疗效评估的应用

Horwitz, S; Coiffier, B; Foss, F; Prince, H M; Sokol, L; Greenwood, M; Caballero, D; Morschhauser, F; Pinter-Brown, L; Iyer, S P; Shustov, A; Nichols, J; Balser, J; Balser, B; Pro, B

Paclitaxel, topotecan and rituximab: long term outcomes of an effective salvage programme for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma

紫杉醇、拓扑替康和利妥昔单抗:复发或难治性侵袭性B细胞非霍奇金淋巴瘤有效挽救治疗方案的长期疗效

Westin, Jason R; McLaughlin, Peter; Romaguera, Jorge; Hagemeister, Fredrick B; Pro, Barbara; Dang, Nam H; Samaniego, Felipe; Rodriguez, Maria A; Fayad, Luis; Oki, Yasuhiro; Fanale, Michelle; Fowler, Nathan; Nastoupil, Loretta; Feng, Lei; Loyer, Evelyn; Younes, Anas